Congress demands Medicare drug cost transparency for seniors
H.R. 6401 — Increasing Medication Access for Seniors Act of 2025 · Filed by Jennifer Kiggans (R-VA) · 1 cosponsor · Introduced Dec 3, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the Secretary of Health and Human Services to report to Congress on how many Medicare Part D beneficiaries are using a monthly capped cost-sharing option for prescription drugs, and what steps HHS is taking to make this option easier to access and understand. The reports must be submitted every 3 months for the first year, then annually through 2031.
Why we flagged it
The bill is a reporting and implementation mandate designed to increase awareness and utilization of an existing Medicare cost-sharing option. It does not create new benefits or change policy; it mandates transparency and operational improvements to help seniors access a benefit that already exists.
What the text implies
- The bill's success depends on HHS actually implementing point-of-sale mechanisms and outreach; if HHS deprioritizes implementation, the reporting requirement alone will not improve access.
- Monthly capped cost-sharing may shift some financial risk from beneficiaries to insurers and the Medicare program, potentially affecting plan design and premiums in future years.
The full analysis lists 3 implications of this text.
Who stands to gain
Medicare beneficiaries (through improved access to cost-predictability); Pharmacy benefit managers and pharmacies (through increased point-of-sale infrastructure investment)